Literature DB >> 18298958

Protein folding diseases and neurodegeneration: lessons learned from yeast.

Joris Winderickx1, Charlotte Delay, Ann De Vos, Harald Klinger, Klaartje Pellens, Thomas Vanhelmont, Fred Van Leuven, Piotr Zabrocki.   

Abstract

Budding yeast Saccharomyces cerevisiae has proven to be a valuable model organism for studying fundamental cellular processes across the eukaryotic kingdom including man. In this respect, complementation assays, in which the yeast protein is replaced by a homologous protein from another organism, have been very instructive. A newer trend is to use the yeast cell factory as a toolbox to understand cellular processes controlled by proteins for which the yeast lacks functional counterparts. An increasing number of studies have indicated that S. cerevisiae is a suitable model system to decipher molecular mechanisms involved in a variety of neurodegenerative disorders caused by aberrant protein folding. Here we review the current knowledge gained by the use of so-called humanized yeasts in the field of Huntington's, Parkinson's and Alzheimer's diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298958     DOI: 10.1016/j.bbamcr.2008.01.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

1.  Temperature-sensitive post-translational regulation of plant omega-3 fatty-acid desaturases is mediated by the endoplasmic reticulum-associated degradation pathway.

Authors:  Jami B O'Quin; Linda Bourassa; Daiyuan Zhang; Jay M Shockey; Satinder K Gidda; Spencer Fosnot; Kent D Chapman; Robert T Mullen; John M Dyer
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Identification of PrP sequences essential for the interaction between the PrP polymers and Aβ peptide in a yeast-based assay.

Authors:  Aleksandr A Rubel; Tatyana A Ryzhova; Kirill S Antonets; Yury O Chernoff; Alexey Galkin
Journal:  Prion       Date:  2013-10-23       Impact factor: 3.931

Review 3.  Yeast prions: structure, biology, and prion-handling systems.

Authors:  Reed B Wickner; Frank P Shewmaker; David A Bateman; Herman K Edskes; Anton Gorkovskiy; Yaron Dayani; Evgeny E Bezsonov
Journal:  Microbiol Mol Biol Rev       Date:  2015-03       Impact factor: 11.056

Review 4.  Modeling ALS and FTLD proteinopathies in yeast: an efficient approach for studying protein aggregation and toxicity.

Authors:  Dmitry Kryndushkin; Frank Shewmaker
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

5.  Yeast cells expressing the human mitochondrial DNA polymerase reveal correlations between polymerase fidelity and human disease progression.

Authors:  Yufeng Qian; Aashiq H Kachroo; Christopher M Yellman; Edward M Marcotte; Kenneth A Johnson
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

6.  Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast.

Authors:  Prashant R Bharadwaj; Giuseppe Verdile; Renae K Barr; Veer Gupta; John W Steele; M Lenard Lachenmayer; Zhenyu Yue; Michelle E Ehrlich; Gregory Petsko; Shulin Ju; Dagmar Ringe; Sonia E Sankovich; Joanne M Caine; Ian G Macreadie; Sam Gandy; Ralph N Martins
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

7.  Synphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner.

Authors:  Sabrina Büttner; Charlotte Delay; Vanessa Franssens; Tine Bammens; Doris Ruli; Sandra Zaunschirm; Rita Machado de Oliveira; Tiago Fleming Outeiro; Frank Madeo; Luc Buée; Marie-Christine Galas; Joris Winderickx
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models.

Authors:  Joshua A Kritzer; Shusei Hamamichi; J Michael McCaffery; Sandro Santagata; Todd A Naumann; Kim A Caldwell; Guy A Caldwell; Susan Lindquist
Journal:  Nat Chem Biol       Date:  2009-07-13       Impact factor: 15.040

Review 9.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

Review 10.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.